首页 > 市场调查报告书 > 医疗设备

医学影像诊断

市场调查报告书

商品编码

1560858

全球医学影像资讯系统市场 - 2024 - 2031

Global Medical Imaging Information Systems Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 224 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球医学影像资讯系统市场2023年达到64亿美元，预计2031年将达到109.7亿美元，2024-2031年预测期间复合年增长率为6.97%。

医学影像资讯系统用于组织和控制医学影像及相关资料。该系统对于监控放射成像请求和付款细节非常有益。此外，医学成像可以与 PACS 和供应商中立存檔 (VNA) 一起使用，以有效处理影像存檔、计费和记录保存。

慢性病发病率上升、对早期疾病诊断和检测工具的需求以及老年人口的不断扩大预计将推动这一扩张。主要企业投资增加、技术发展（包括人工智慧（AI）在医学影像中的整合）以及床边医疗影像设备的开发等因素可能会进一步推动这一扩张。

日本的老年人口比例最高，义大利、德国、法国和丹麦的老年人口比例预计今后也将最高。这是由于近年来预期寿命的大幅提高，预计这种模式将持续下去。预计到 2050 年，香港、韩国和日本将有近 40% 的人口年龄在 65 岁或以上。与高度开发地区的现有比例相比，这一比例显着上升，这些地区只有约 20% 的人口属于这个年龄层。

市场动态

全球预期寿命的延长和慢性病盛行率的上升是关键的成长动力：

随着人们寿命的延长，他们罹患慢性病的可能性也随之增加。医学影像无需侵入性治疗即可提供人体内部状况的完整视觉化，在精确诊断、控制和治疗疾病方面发挥着至关重要的作用。因此，随着全球人口老化，诊断影像服务的需求预计会增加，这将推动市场扩张。这一趋势凸显了复杂成像技术在满足日益老龄化人口的医疗保健需求方面的重要性。根据联合国估计，2021 年新生儿的平均寿命比 1950 年出生的人长近 25 年。

医学影像有助于及时、准确地识别疾病，从而实现有效的治疗。根据美国国家卫生统计中心估计，2023 年该国新增癌症病例约 1,958,310 例，癌症死亡人数为 609,820 人。此外，慢性病的激增极大地增加了对医学影像的需求，导致全球范围内诊断影像检查的升级。世界卫生组织 (WHO)资料显示，全球每年进行约 36 亿次诊断测试，其中约 3.5 亿次涉及儿科患者。

医学影像的监管障碍：安全标准和市场影响：

法规对医学影像产业产生重大影响，因为商品必须遵守美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构制定的严格安全性和有效性标准。将新型成像技术引入市场的过程漫长且成本高昂，法律的影响显而易见。 2023 年 12 月，美国食品药物管理局 (FDA) 将飞利浦医疗影像设备（特别是某些型号的 Panorama 1.0T HFO 设备（MRI 系统））的召回列为最严重等级。此分类意味着使用这些设备可能会导致严重伤害甚至死亡。之所以采取这项措施，是因为担心在「淬火程序」期间，由于氦气过量积聚，可能会发生爆炸。消息公布后，在美上市的飞利浦股价下跌约1%。

细分市场分析

全球医学影像资讯系统市场根据感测器技术、软体、应用、最终用户和地区进行细分。

磁振造影领域占据最大的市场份额：

MRI 系统用于对多个器官进行影像，例如腹部、骨盆、大脑、脊椎、心臟、乳房和肌肉骨骼结构。 2023 年 6 月，GE HealthCare 宣布 FDA 已批准并发布 Sonic DL，这是一项由深度学习驱动的技术，可显着加速磁振造影 (MRI) 中影像的撷取过程。

预测表明，MRI 技术的进步扩大了其应用范围，将推动市场扩张。由于最近的进步，例如采用纤维束成像的扩散和扩散张量成像、灌注成像、包括磁振造影波谱在内的神经成像方法以及采用 BOLD 方法进行功能成像，磁振造影市场可能会经历扩张。此外，术中 MRI 技术的不断进步，加上其在神经外科等领域的广泛应用，预计将推动市场扩张。

电脑断层扫描部分产生高解析度影像，使医疗保健提供者能够以极高的清晰度可视化内部结构，从而协助诊断和治疗多种医学疾病。 CT 扫描经常用于识别器官、组织和骨骼的异常情况，以及协助手术介入。由于技术的突破，CT 影像在速度、准确性和安全性方面都得到了提高，使其成为跨多个医学学科的医疗诊断和患者护理的宝贵工具。

市场地域占有率

北美的医疗影像资讯系统市场估计占最大份额：

北美地区的成长可归因于多种因素，包括医疗影像技术在初级保健机构中的利用率提高、可及性的提高以及拥有有效报销计划的国家的大量医疗保健支出。乳癌、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升，这导致了对影像分析的巨大需求。预计该地区将在预测期内继续保持其主导地位。由于技术创新和慢性病盛行率的上升，预计该区域市场的成长将进一步加速。

2023年，美国医学影像市场占据北美市场相当大的份额。这些变化可归因于技术进步、患者护理实践的改变以及流行病学趋势的发展等变数。全国城市和农村地区对医学影像领域放射科医师的需求仍然强劲。据美国放射技术专家协会称，约有 35 万名放射科医生在医疗机构註册并工作。此外，美国劳工统计局预测，到 2030 年，放射和 MRI 技术人员的就业人数将增加 9%，从而创造 21,600 个新职缺。

COVID-19 影响分析

COVID-19 大流行凸显了这些技术在我们应对突发公共卫生事件的能力中的重要性。 X 光、CT 扫描和超音波等医学影像技术在诊断和监测这些疾病方面发挥着不可估量的作用，使医疗保健提供者能够就病患照护做出明智的决策。

医学影像技术凭藉其诊断能力，在应对疫情方面发挥了关键作用。例如，X 光和 CT 扫描可帮助医疗保健提供者确定哪些患者需要住院治疗，从而实现资源和人员的有效分配。医学影像也用于监测从 COVID-19 中恢復的患者，为疾病的进展和各种治疗的有效性提供有价值的见解。

推动这一成长的主要因素之一是对先进医学影像设备的需求，以提供详细、高解析度的肺部影像。多家医学影像公司根据需求开发了专门用于 COVID-19 诊断和监测的新技术。例如，佳能医疗系统最近推出了一款新软体包，可以使用 CT 扫描快速且准确地诊断 COVID-19 肺炎。

俄乌战争影响分析

俄罗斯和乌克兰之间持续的衝突对医学影像业务产生了重大影响，主要是因为乌克兰的医院基础设施遭受了广泛的破坏。暴力事件导致医院和诊所等多个医疗设施遭到蓄意攻击和破坏，对重要卫生服务的提供造成严重干扰。因此，目前医疗资源短缺，医学影像等诊断服务功能有限。战争加剧了维护和增强成像设备的挑战，导致及时、准确诊断急性和慢性疾病的能力下降。

此外，暴力事件导致预防性和诊断性治疗等常规医疗服务大幅减少，加剧了人道灾难。由于众多医疗机构遭到广泛破坏或破坏，以及必要资源的供应有限，该地区的医学影像市场被迫迅速调整。持续的不稳定性导致对行动和便携式成像设备以及远端诊断技术的需求增加，以满足受暴力影响地区流离失所群体和个人的医疗保健需求。然而，持续的不稳定和资源稀缺仍然是市场復苏和成长的重大障碍。

按产品分类

X射线设备

射线照相

透视

乳房X光摄影

超音波

手持式

袖珍的

基于手推车/手推车

电脑断层扫描

高端切片CT

中端断层CT

低端切片CT

锥束CT

磁振造影

封闭系统

开放系统

核子造影

SPECT

宠物

按申请

心臟病学

骨科

胃肠病学

妇科

肿瘤学

神经病学

其他

按最终用户

诊断中心

医院

专科诊所

其他的

按地区

北美洲

我们

加拿大

墨西哥

欧洲

德国

英国

法国

义大利

俄罗斯

欧洲其他地区

南美洲

巴西

阿根廷

南美洲其他地区

亚太

中国

印度

日本

澳洲

亚太其他地区

中东和非洲

主要进展

2024年1月，佳能医疗系统公司和奥林巴斯公司宣布合作，共同开发超音波内视镜系统。根据该协议，佳能医疗被指定负责开发和生产用于内视镜超音波检查的超音波诊断设备。另一方面，奥林巴斯将负责销售和行销工作。该协议的目的是将佳能用于 EUS 的 Aplio i800 超音波诊断系统与奥林巴斯超音波内视镜的功能相结合，旨在向市场提供先进的 EUS 设备，保证卓越的影像诊断。

佳能医疗系统于 2023 年 11 月公布了对其 CT 产品线的重大增强，包括推出两台新扫描仪。在美国伊利诺州芝加哥举行的北美放射学会大会 (RSNA) 上首次亮相，展示了两款新型号：豪华型号 Aquilion ONE / INSIGHT 版和专为提高效率而打造的 Aquilion Serve SP。

GE Healthcare 于 2023 年 2 月表示，已同意收购 Caption Health, Inc.，一家私人人工智慧医疗保健服务提供商。 Caption Health 专注于创建旨在促进早期疾病诊断的临床应用程式。该公司利用人工智慧（AI）技术协助超音波扫描分析。

2023 年 5 月，皇家飞利浦 NV 推出了飞利浦 CT 3500，这是一款专为常规放射学和大容量筛检专案而设计的先进 CT 系统。

GE Healthcare 采用先进的 NVIDIA 技术，于 2024 年 3 月成功生产了最新的研究模式 SonoSAMTrack1。这种新颖的方法是基于名为 SonoSAM1 的基本模型，该模型是专门为分割超音波影像中的物件而创建的。 SonoSAMTrack 的主要目的是准确识别和勾画超音波影像中的解剖结构、病灶和其他重要区域。此外，还生产了该范例的一个不太复杂的版本，称为 SonoSAMLite。

2024 年 1 月，佳能推出了 Aplio me，这是一种先进的超音波系统，旨在满足各种医疗环境中普通用户的多样化需求。这种高度便携且轻巧的系统非常适合强调工作流程最佳效率并正在寻找适用于小型诊所和大型医院的先进标准解决方案的超音波专业人员。

市场竞争格局

市场的主要全球参与者包括GE Healthcare、Koninklijke Philips NV、Siemens Healthineers、Canon Medical Systems Corporation、Mindray Medical International、FUJIFILM VisualSonics Inc.、Carestream Health、Hitachi、Samsung Medison Co., Ltd.、Koning Corporation、PerkinElmer Inc Inc . .、柯尼卡美能达、Esaote、Hologic, Inc.、Varex Imaging

为什么购买报告？

根据产品、应用程式、最终用户和地区可视化全球医学影像资讯系统市场细分，并了解关键商业资产和参与者。

透过分析趋势和共同开发来识别商业机会。

Excel资料表，包含所有细分市场层级的医学影像资讯系统的大量资料点。

PDF 报告由详尽的质性访谈和深入研究后的综合分析组成。

产品映射以 Excel 形式提供，包含所有主要参与者的关键产品。

全球医学影像资讯系统市场报告将提供约 86 个表格、85 个图表和 224 页。

2024 年目标受众

製造商/买家

产业投资者/投资银行家

研究专业人员

新兴公司

A medical imaging information system is utilized for the organization and control of medical images and related data. This system is very beneficial for monitoring radiology imaging requests and payment details. Furthermore, medical imaging can be utilized alongside PACS and Vendor Neutral Archive (VNAs) to effectively handle image archives, billing, and record-keeping.

This expansion is expected to be driven by the rising incidence of chronic diseases, the need for early disease diagnostic and detection tools, and the expanding geriatric population. The expansion is likely to be further fueled by factors such as increasing investments from major businesses, developments in technology including the integration of Artificial Intelligence (AI) in medical imaging, and the development of point-of-care medical imaging equipment.

Japan has the largest proportion of old people, with Italy, Germany, France, and Denmark expected to have the greatest proportions, going forward. This is attributed to substantial advancements in life expectancy in recent years, a pattern that is projected to persist. By the year 2050, it is projected that almost 40% of the population in Hong Kong, South Korea, and Japan will consist of individuals who are 65 years of age or older. This is a significant rise compared to the existing proportions in highly developed areas, where only approximately 20% of the population belongs to this age bracket.

Market Dynamics

A rise in global life expectancy and the growing prevalence of chronic diseases are crucial growth drivers:

As individuals experience increased longevity, their vulnerability to chronic illnesses rises. Medical imaging plays a crucial role in precisely diagnosing, controlling, and treating diseases by providing full visualizations of the body's internal condition without the need for invasive treatments. Consequently, with the aging of the worldwide population, there is an anticipated increase in the demand for diagnostic imaging services, which will drive market expansion. This trend highlights the significance of sophisticated imaging technology in addressing the healthcare requirements of a progressively older population. As per the United Nations, the estimated average lifetime of a newborn in 2021 is almost 25 years longer than that of an individual born in 1950. The average age is expected to reach 71 years, with females typically outliving males by five years.

Medical imaging facilitates the prompt and precise identification of disorders, allowing for efficient therapy. In 2023, the US National Center for Health Statistics estiamted around 1,958,310 new cases of cancer and 609,820 deaths caused by cancer in the country. Moreover, the surge in chronic ailments has greatly enhanced the need for medical imaging, leading to a worldwide escalation in diagnostic imaging examinations. The World Health Organization (WHO) data reveals that around 3.6 billion diagnostic tests are performed globally each year, with approximately 350 million of these procedures involving pediatric patients.

Regulatory Hurdles in Medical Imaging: Navigating Safety Standards and Market Impacts:

Regulations have a substantial impact on the medical imaging sector, as goods are required to adhere to strict safety and effectiveness criteria established by regulatory authorities including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The influence of laws is evident in the protracted and costly procedure of introducing novel imaging technology to the market. In December 2023, the US Food and Drug Administration (FDA) categorized the recall of Philips' medical imaging devices, specifically certain models of the Panorama 1.0T HFO device (MRI Systems), as the highest level of severity. This classification signifies that using these devices could potentially result in severe injuries or even death. This measure is being taken because there are concerns that an explosion could happen during a "quench procedure" as a result of an excessive buildup of helium gas. After the announcement, the stock of Philips listed in the US experienced a decline of around 1%.

Market Segment Analysis

The global medical imaging information systems market is segmented based on sensor Technology, Software, Application, End-user and region.

The magnetic resonance imaging segment accounted for the largest market share:

MRI systems are used for imaging several organs, such as the belly, pelvis, brain, spine, heart, breast, and musculoskeletal structure. In June 2023, GE HealthCare announced that the FDA had approved and released Sonic DL, a technology-driven by deep learning that significantly speeds up the process of obtaining images in magnetic resonance imaging (MRI).

Predictions indicate that advancements in MRI technology, to expand their variety of applications, will drive market expansion. The magnetic resonance imaging market is likely to experience expansion due to recent advancements such as diffusion and diffusion tensor imaging employing tractography, perfusion imaging, neuroimaging approaches including MR spectroscopy, and adopting the BOLD methodology for functional imaging. Furthermore, the increasing progress in intraoperative MRI technology, coupled with its many applications in fields such as neurosurgery, is expected to drive market expansion.

The computed tomography section generates high-resolution images that enable healthcare providers to visualize inside structures with outstanding clarity, thereby assisting in the diagnosis and treatment of numerous medical disorders. CT scans are frequently employed for the identification of anomalies in organs, tissues, and bones, as well as for assisting in surgical interventions. Due to technology breakthroughs, CT imaging has experienced improvements in speed, accuracy, and safety, making it a valuable tool in medical diagnosis and patient care across multiple medical disciplines.

Market Geographical Share

The medical imaging information systems market in North America is estimated to account for the largest share:

The growth in the North American region can be ascribed to several factors, including the heightened utilization of medical imaging technologies in primary care settings, enhanced accessibility, and substantial healthcare expenditure in countries with effective reimbursement schemes. There is a growing prevalence of chronic illnesses, such as breast cancer, cardiovascular disorders, and neurological diseases, which has led to a significant need for imaging analysis. The region is projected to continue its dominant position during the predicted period. The regional market growth is expected to be further accelerated by technological innovations and the increasing prevalence of chronic illnesses.

In 2023, the medical imaging market in the U.S. had a substantial portion of the North American market. These changes can be ascribed to variables such as the progress of technologies, the modification of patient care practices, and the development of epidemiological trends. The demand for radiologists in the field of medical imaging remains strong throughout both urban and rural areas throughout the country. According to the American Society of Radiologic Technologists, around 350,000 radiologists are registered and working in healthcare settings. In addition, the U.S. Bureau of Labor Statistics predicts a 9% increase in the employment of radiologic and MRI technologists by 2030, leading to the creation of 21,600 new job openings.

COVID-19 Impact Analysis

The COVID-19 pandemic underscored the importance of these technologies in our capacity to address public health emergencies. Medical imaging technologies like X-rays, CT scans, and ultrasounds have been invaluable in diagnosing and monitoring these conditions, enabling healthcare providers to make informed decisions about patient care.

Medical imaging technologies played a critical role in managing the pandemic, thanks to their diagnostic capabilities. For example, X-rays and CT scans helped healthcare providers identify which patients required hospitalization, allowing for the efficient allocation of resources and personnel. Medical imaging was also used to monitor patients recovering from COVID-19, providing valuable insights into the progression of the disease and the effectiveness of various treatments.

One of the main factors that drove this growth was the demand for advanced medical imaging equipment to offer detailed, high-resolution images of the lungs. Several medical imaging companies developed new technologies specifically designed for COVID-19 diagnosis and monitoring in response to the demand. For instance, Canon Medical Systems recently introduced a new software package that enabled quick and accurate diagnosis of COVID-19 pneumonia using CT scans.

Russia-Ukraine War Impact Analysis

The ongoing conflict between Russia and Ukraine has had a substantial impact on the medical imaging business, mainly because of the extensive damage caused to hospital infrastructure in Ukraine. The violence has resulted in the intentional targeting and destruction of multiple medical facilities, such as hospitals and clinics, causing significant disruption to the provision of vital health services. As a result, there is currently a shortage of medical resources and a limited functioning of diagnostic services, such as medical imaging. The war has exacerbated the challenges in maintaining and enhancing imaging equipment, resulting in a diminished ability to promptly and accurately diagnose both acute and chronic illnesses.

Moreover, the violence has resulted in a significant decrease in regular healthcare services, such as preventative and diagnostic treatment, exacerbating the humanitarian disaster. Due to the extensive damage or destruction of numerous healthcare institutions and the restricted availability of necessary resources, the medical imaging market in the region has been compelled to swiftly adjust. The ongoing instability has resulted in an increased demand for mobile and portable imaging devices, together with remote diagnostic technology, to meet the healthcare needs of displaced groups and individuals in regions impacted by violence. However, the ongoing instability and scarcity of resources remain significant barriers to the market's recovery and growth.

By Product

X-ray Devices

Radiography

Fluoroscopy

Mammography

Ultrasound

Handheld

Compact

Cart/Trolley based

Computed Tomography

High-end slice CT

Mid-end slice CT

Low-end slice CT

Cone beam CT

Magnetic Resonance Imaging

Closed system

Open system

Nuclear Imaging

SPECT

PET

By Application

Cardiology

Orthopedics

Gastroenterology

Gynecology

Oncology

Neurology

Other

By End-user

Diagnostic Centers

Hospitals

Specialty Clinics

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Russia

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In January 2024, Canon Medical Systems Corporation and Olympus Corporation announced their collaboration to jointly develop Endoscopic Ultrasound Systems. According to this agreement, Canon Medical has been assigned the responsibility of developing and producing diagnostic ultrasound equipment for Endoscopic Ultrasonography. On the other side, Olympus will be in charge of the sales and marketing efforts. The objective of this agreement is to combine the functionalities of Canon's Aplio i800 diagnostic ultrasound system for EUS with Olympus' Ultrasound Endoscope, with the goal of providing sophisticated EUS equipment to the market, guaranteeing exceptional imaging diagnostics.

Canon Medical Systems unveiled substantial enhancements to its CT product line in November 2023, including the introduction of two new scanners. The debut at the Radiological Society of North America Congress (RSNA) in Chicago, Illinois, USA showcased two new models: the Aquilion ONE / INSIGHT Edition, a luxury model, and the Aquilion Serve SP, built for great efficiency.

GE Healthcare stated in February 2023 that it has agreed to acquire Caption Health, Inc., a privately held provider of AI healthcare services. Caption Health specializes in the creation of clinical applications designed to facilitate early disease diagnosis. The company leverages artificial intelligence (AI) technology to assist in the analysis of ultrasound scans.

In May 2023, Koninklijke Philips N.V. introduced the Philips CT 3500, a sophisticated CT system designed specifically for routine radiology and high-volume screening programs.

GE Healthcare successfully produced its most recent research model, SonoSAMTrack1, in March 2024, employing advanced NVIDIA technology. This novel approach is based on a fundamental model called SonoSAM1, which is specifically created for segmenting objects in ultrasound images. SonoSAMTrack's main purpose is to accurately identify and outline anatomical structures, lesions, and other important areas in ultrasound images. Additionally, a less complex version of this paradigm, called SonoSAMLite, has been produced.

In January 2024, Canon unveiled Aplio me, an advanced ultrasound system designed to meet the diverse requirements of regular users in a wide range of medical settings. This highly portable and lightweight system is perfect for ultrasound professionals that emphasize optimal efficiency in their workflow and are looking for advanced standard solutions, suitable for both tiny clinics and larger hospitals.

Market Competitive Landscape

The major global players in the market include GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corporation, Mindray Medical International, FUJIFILM VisualSonics Inc., Carestream Health, Hitachi, Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., Konica Minolta, Esaote, Hologic, Inc., Varex Imaging

Why Purchase the Report?

To visualize the global medical imaging information systems market segmentation based on product, application, end-user and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of medical imaging information systems market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global medical imaging information systems market report would provide approximately 86 tables, 85 figures, and 224 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End-user
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. A Rise In Global Life Expectancy And The Growing Prevalence Of Chronic Diseases Are Critical Growth Driver
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Hurdles In Medical Imaging: Navigating Safety Standards And Market Impacts
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. By Product

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 6.1.2. Market Attractiveness Index, By Product
6.2. X-ray Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Radiography
- 6.2.4. Fluoroscopy
- 6.2.5. Mammography
6.3. Ultrasound
- 6.3.1. Handheld
- 6.3.2. Compact
- 6.3.3. Cart/Trolley based
6.4. Computed Tomography
- 6.4.1. High-end slice CT
- 6.4.2. Mid-end slice CT
- 6.4.3. Low-end slice CT
- 6.4.4. Cone beam CT
6.5. Magnetic Resonance Imaging
- 6.5.1. Closed system
- 6.5.2. Open system
6.6. Nuclear Imaging
- 6.6.1. SPECT
- 6.6.2. PET

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Cardiology *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Orthopedics
7.4. Gastroenterology
7.5. Gynecology
7.6. Oncology
7.7. Neurology
7.8. Others

8. By End-user

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 8.1.2. Market Attractiveness Index, By End-user
8.2. Diagnostic Centers *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals
8.4. Specialty Clinics
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. Australia
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. GE Healthcare *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Koninklijke Philips N.V.
11.3. Siemens Healthineers
11.4. Canon Medical Systems Corporation
11.5. Mindray Medical International
11.6. FUJIFILM VisualSonics Inc.
11.7. Carestream Health
11.8. Hitachi
11.9. Samsung Medison Co., Ltd.
11.10. Koning Corporation
11.11. PerkinElmer Inc.
11.12. Konica Minolta
11.13. Esaote
11.14. Hologic, Inc.
11.15. Varex Imaging (*LIST NOT EXHAUSTIVE)